GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (HKSE:00950) » Definitions » Forward Dividend Yield %

Lee's Pharmaceutical Holdings (HKSE:00950) Forward Dividend Yield % : 3.09% (As of Jul. 21, 2025)


View and export this data going back to 2002. Start your Free Trial

What is Lee's Pharmaceutical Holdings Forward Dividend Yield %?

As of today (2025-07-21), the Forward Annual Dividend Yield of Lee's Pharmaceutical Holdings is 3.09%.

As of today (2025-07-21), the Trailing Annual Dividend Yield of Lee's Pharmaceutical Holdings is 2.77%.

HKSE:00950's Forward Dividend Yield % is ranked better than
73.74% of 495 companies
in the Drug Manufacturers industry
Industry Median: 1.83 vs HKSE:00950: 3.09

Lee's Pharmaceutical Holdings's Dividends per Share for the six months ended in Dec. 2024 was HK$0.02.

During the past 12 months, Lee's Pharmaceutical Holdings's average Dividends Per Share Growth Rate was 66.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -21.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -25.60% per year. During the past 10 years, the average Dividends Per Share Growth Rate was -13.60% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Lee's Pharmaceutical Holdings was 36.20% per year. The lowest was -34.80% per year. And the median was 7.70% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Lee's Pharmaceutical Holdings's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Lee's Pharmaceutical Holdings's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lee's Pharmaceutical Holdings's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lee's Pharmaceutical Holdings's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Lee's Pharmaceutical Holdings's Forward Dividend Yield % falls into.


;
;

Lee's Pharmaceutical Holdings Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Lee's Pharmaceutical Holdings Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
HKD 0.0250002025-05-282025-05-302025-06-16Cash Dividendsemi-annuallyHKD:HKD 1.000000
HKD 0.0200002024-09-122024-09-162024-10-03Cash Dividendsemi-annuallyHKD:HKD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Lee's Pharmaceutical Holdings's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.05/1.62
=3.09 %

Current Share Price is HK$1.62.
Lee's Pharmaceutical Holdings's Dividends per Share for the forward twelve months is calculated as HK$0.025 * 2 = HK$0.05.

Lee's Pharmaceutical Holdings's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.045/1.62
=2.78 %

Current Share Price is HK$1.62.
Lee's Pharmaceutical Holdings's Dividends per Share for the trailing twelve months (TTM) ended in Today is HK$0.045.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lee's Pharmaceutical Holdings  (HKSE:00950) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Lee's Pharmaceutical Holdings Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lee's Pharmaceutical Holdings Business Description

Traded in Other Exchanges
N/A
Address
Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG
Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.
Executives
Leelalertsuphakun Wanee 2101 Beneficial owner
Lion River I N.v. 2201 Interest of corporation controlled by you
Li Zhenfu 2201 Interest of corporation controlled by you
Assicurazioni Generali Spa 2201 Interest of corporation controlled by you
Huang Zuie-chin 2201 Interest of corporation controlled by you
Lue Shuk Ping Vicky 2202 Interest of your spouse
Li Xiaoyi 2101 Beneficial owner
Lee Siu Fong 2101 Beneficial owner
Ubs Group Ag 2201 Interest of corporation controlled by you
Panacea Venture Healthcare Fund Ii, L.p. 2101 Beneficial owner
Panacea Innovation Limited 2201 Interest of corporation controlled by you
Guang Dong Min Ying Tou Zi Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Apta Finance Sa 2201 Interest of corporation controlled by you
Qualister Sa 2101 Beneficial owner
Paponi Claudia 2202 Interest of your spouse

Lee's Pharmaceutical Holdings Headlines

No Headlines